CRDO
Credo Technology Group Holding Ltd
CRDO's fundamentals are strong and it looks cheap: trading at 49x earnings, less than half its usual 124x. Analysts expect strong earnings growth.
QBTS
D-Wave Quantum Inc.
There isn't enough reported data to score QBTS yet.
CRDO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CRDO's revenue, profitability, cash flow and balance sheet are all currently healthy.
QBTS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
QBTS's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
CRDO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $140 | — |
| Current | 49x | $140 | — |
| Cheap | 75x | $212 | +52% |
| Fair | 124x | $353 | +152% |
| Expensive | 395x | $1,122 | +703% |
Historical ranges are pointers, not guarantees.
CRDO's PE is in its cheap range at 49x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
QBTS PE Valuation
QBTS has no meaningful PE right now: it lost money over the past year.
CRDO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for CRDO, with profitability improving.
QBTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect QBTS's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
CRDO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.35 | +194% |
| Q3 2026 | $2.84 | +312% |
| Q2 2026 | $2.51 | +766% |
| Q1 2026 | $1.82 | +18100% |
| Q4 2025 | $1.16 | +$1.31 |
| Q3 2025 | $0.69 | +$0.85 |
| Q2 2025 | $0.29 | +$0.47 |
| Q1 2025 | $0.01 | +$0.24 |
| Q4 2024 | -$0.15 | +$0.06 |
CRDO has the edge over QBTS in the latest year-over-year earnings comparison.
QBTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.44 | +$0.97 |
QBTS is still losing money, but far less than before: $0.44 per share over the past year, against $1.41 at its worst in late 2025.
CRDO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $479M | +115% |
| Q2 2026 | $437M | +157% |
| Q1 2026 | $407M | +201% |
| Q4 2025 | $268M | +272% |
| Q3 2025 | $223.1M | +274% |
| Q2 2025 | $170M | +180% |
| Q1 2025 | $135M | +154% |
| Q4 2024 | $72M | +64% |
CRDO has the edge over QBTS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 25% | -2 points |
| Q2 2026 | 36% | +16 points |
| Q1 2026 | 37% | +17 points |
| Q4 2025 | 29% | +41 points |
| Q3 2025 | 27% | +51 points |
| Q2 2025 | 20% | +33 points |
| Q1 2025 | 19% | +31 points |
| Q4 2024 | -12% | +8.5 points |
CRDO has the edge over QBTS on profitability, with a higher operating margin.
QBTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.5M | +21% |
| Q2 2026 | $3.1M | -0.6% |
| Q1 2026 | $2.9M | -81% |
| Q4 2025 | $2.8M | +19% |
QBTS's revenue is recovering but still below its 2025 peak: $5M last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1732% | -876 points |
| Q1 2026 | -1915% | -1840 points |
| Q4 2025 | -1266% | -390 points |
| Q3 2025 | -742% | N/A |
| Q2 2025 | -856% | N/A |
| Q1 2025 | -75% | N/A |
| Q4 2024 | -876% | N/A |
QBTS's operating margin was −1732% last quarter, down 876 points from the same quarter a year ago.
CRDO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $82.9M | +62% |
| Q2 2026 | $177.5M | +228% |
| Q1 2026 | $139.7M | +$140.1M |
| Q4 2025 | $38.5M | +$50.1M |
| Q3 2025 | $51.3M | +$64.4M |
| Q2 2025 | $54.2M | +5531% |
| Q1 2025 | -$383K | +$5.8M |
| Q4 2024 | -$11.7M | -494% |
CRDO has burned cash in most quarters: $439M over the past year, about five times what it generated the year before.
QBTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$32.9M | -$16.9M |
| Q1 2026 | -$46M | -$26.3M |
| Q4 2025 | -$20M | -1977% |
QBTS and CRDO do not have enough comparable growth data to identify a winner.
CRDO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +6.1M shares |
| 1 year | +5.3% | +9.8M shares |
| 3 years | +30% | +45.1M shares |
| 5 years | +39% | +54.4M shares |
CRDO has the edge over QBTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $22.9M |
| Q3 2020 | — |
QBTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +3.4M shares |
| 1 year | +23% | +68.6M shares |
QBTS has 371M diluted shares, up 23% from a year ago.
CRDO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | -2.4x | Net Cash |
| Q1 2026 | -3.5x | Net Cash |
| Q4 2025 | -2.5x | Net Cash |
| Q3 2025 | -1.6x | Net Cash |
| Q2 2025 | -4.0x | Net Cash |
| Q1 2025 | -22.2x | Net Cash |
CRDO has more cash than debt.
QBTS Net Leverage
QBTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CRDO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.0 | Neutral |
| Stochastic | 9.2 | Oversold |
CRDO's weekly RSI is 42 (neutral) and its Stochastic is 9 (oversold).
QBTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.7 | Neutral |
| Stochastic | 10.0 | Oversold |
QBTS's weekly RSI is 32 (neutral) and its Stochastic is 10 (oversold).
CRDO PE vs Technology Sector
| Metric | CRDO | Sector median | Relative |
|---|---|---|---|
| PE | 49x | 28x | 77% above |
| PE % | 1 | 48 | 47 pts below |
CRDO is trading at 49x earnings, a 77% premium to the Technology sector's median of 28x.
QBTS PE vs Technology Sector
QBTS has no meaningful PE right now: it lost money over the past year.
CRDO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $171.8 | 19% below |
| 20 week MA | $199.0 | 30% below |
| 50 week MA | $174.7 | 20% below |
| 100 week MA | $134.3 | 4.1% above |
| 200 week MA | $78.2 | 79% above |
CRDO has the edge over QBTS on trend strength, trading above more of its moving averages.
QBTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.8 | 23% below |
| 20 week MA | $16.3 | 40% below |
| 50 week MA | $19.9 | 50% below |
| 100 week MA | $17.6 | 44% below |
| 200 week MA | $9.46 | 4% above |
QBTS has fallen below most of its moving averages, though it's still 4% above its 200-week average.
CRDO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $11.2 | $13.0 | +16% |
| 2023 | $13.0 | $19.5 | +50% |
| 2024 | $19.5 | $69.3 | +256% |
| 2025 | $69.3 | $144.8 | +109% |
| 2026 YTD | $144.8 | $139.8 | -3.5% |
CRDO has the edge over QBTS on returns for 2026, with the stronger performance.
QBTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.2 | $10.5 | +3.4% |
| 2021 | $10.5 | $9.79 | -6.8% |
| 2022 | $9.79 | $1.70 | -83% |
| 2023 | $1.70 | $0.88 | -48% |
| 2024 | $0.88 | $9.91 | +1026% |
| 2025 | $9.91 | $25.3 | +155% |
| 2026 YTD | $25.3 | $9.84 | -61% |
QBTS's yearly returns have swung widely, from +1026% in 2024 to −83% in 2022. It's down 61% so far in 2026.